The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Halcion 125 micrograms Tablets

125 microgram(s) Tablet

Pfizer Healthcare IrelandPA0822/129/002

Main Information

Trade NameHalcion 125 micrograms Tablets
Active SubstancesTriazolam
Strength125 microgram(s)
Dosage FormTablet
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/129/002

Group Information

ATC CodeN05CD Benzodiazepine derivatives
N05CD05 triazolam

Status

Authorised/WithdrawnAuthorised
Licence Issued13/11/1984
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back